causes

Nutritional drink against early-stage Alzheimer’s? First non-pharmacological study to show long-term success.

By |2021-01-12T18:52:25+01:0013. January 2021|Categories: causes, clinical trial, forms of treatment, micronutrient deficiencies, nutrition, prevention, uncategorized|

Can the course of early Alzheimer's disease be delayed by consuming a special mixture of nutrients? This question was investigated in the European study called 'LipiDiDiet' led by Prof. Tobias Hartmann.  The scientists recruited Alzheimer's patients, who were in the early stages of the disease, to test the effectiveness of a specific nutritional drink called 'Souvenaid'. Souvenaid was developed as a medical dietary food for the treatment of early-stage Alzheimer's disease and is marketed by Nutricia (Danone Group). It contains a defined nutrient combination of long-chain omega-3 fatty acids, phospholipids, choline, B vitamins (B6, B12 and folic acid), vitamins C and E, selenium and uridine monophosphate. 

Gut microbiome and Alzheimer’s disease

By |2020-11-04T08:31:04+01:004. November 2020|Categories: causes, forms of treatment, nutrition, prevention, Prevention|

The fact that our health begins in the gut has been known for thousands of years. Today it is clear that our intestines are more than just a "digestive tube", as this important organ fulfils a variety of other functions. For example, a disturbance of gut health is directly related to the development of chronic diseases.  The intestinal flora, i.e. the microbial colonization of the intestinal mucosa, plays a particularly important role in this process. The intestinal flora is also known as the 'intestinal microbiota'. It is the most important part of our immune system and thus offers us effective protection against infection.

Lifespan cognitive reserve is a protective factor against dementia

By |2020-10-13T14:37:52+02:0014. October 2020|Categories: causes, prevention|

Not everyone grows old the same way. The occurrence of dementia is also not the same in every person. While some people can live longer with good cognitive function and no signs of memory loss (even in the presence of severe neurological disease), others suffer from cognitive and memory impairment without so many brain damages in neurological tests.

New blood tests for Alzheimer’s disease predict pathological brain changes early

By |2020-08-11T18:55:47+02:0012. August 2020|Categories: causes, clinical trial, prevention|

The diagnosis of Alzheimer’s disease (AD) has challenged neurologists for many years. It’s difficult to determine if someone will develop AD in the future, if the actual cognitive deficit is due to AD or to other cause of dementia and it’s also difficult to predict the pace or speed of disease progression.

Alzheimer gene triggers early collapse of the blood-brain barrier and predicts cognitive decline

By |2020-08-01T19:45:16+02:0015. July 2020|Categories: causes, prevention|

Although scientists have known for a long time that apolipoprotein E4 is a leading genetic risk factor for Alzheimer's disease, it has long been unknown how exactly it leads to memory loss. US researchers now believe they have an answer. 

Against any narrow-minded Ignorance: Intervention Studies and Information Sources on Dementia

By |2020-06-16T18:56:03+02:0017. June 2020|Categories: causes, clinical trial, forms of treatment, prevention|Tags: , , |

You go to a doctor - usually a neurologist - ask about natural or lifestyle-oriented therapeutic methods for dementia - and you often look into blank eyes, at worst into an aggressively wrinkled forehead "Don't give me that, all dangerous nonsense, there are only a few pharmacological approaches that may really work!" 

Long-term healthy diet may preserve memory 

By |2020-04-27T14:44:20+02:0029. April 2020|Categories: causes, clinical trial, nutrition, prevention|

A study published in The American Journal of Medicine 2018, has demonstrated that maintaining a healthy diet in midlife is independently associated with a larger hippocampus years later and may protect against cognitive decline. The hippocampus is a structure located in the temporal lobe of each brain hemisphere and is directly involved in the process of memory. The volume of the hippocampus can be determined by brain magnetic resonance imaging (MRI). Decreasing of its volume is related to cognitive impairment and is used in clinical practice for the diagnosis of Alzheimer’s disease (hippocampus atrophy).

The brain can also be infected: Viruses and microorganisms as possible causes of Alzheimer’s dementia

By |2020-04-08T19:56:13+02:008. April 2020|Categories: causes, Infections|Tags: , , , |

The American researcher Dr. Pat McGeer researched whether viruses could possibly cause the alteration of brain cells. He stained brain cells of patients who died with AD using a different staining method. Although he found no evidence of a virus, he found vast amounts of certain brain cells (so-called microglia). These cells only appear in such big amount under certain condition: inflammation! Dr. McGeer researched that microglia had already been discovered in the brain of dementia patients in 1919. However, this theory was not further investigated by that time, but is currently receiving new attention.

Go to Top